168 related articles for article (PubMed ID: 35665804)
1. Targeted Assessment of Mucosal Immune Gene Expression Predicts Clinical Outcomes in Children with Ulcerative Colitis.
Clarkston K; Karns R; Jegga AG; Sharma M; Fox S; Ojo BA; Minar P; Walters TD; Griffiths AM; Mack DR; Boyle B; LeLeiko NS; Markowitz J; Rosh JR; Patel AS; Shah S; Baldassano RN; Pfefferkorn M; Sauer C; Kugathasan S; Haberman Y; Hyams JS; Denson LA; Rosen MJ
J Crohns Colitis; 2022 Nov; 16(11):1735-1750. PubMed ID: 35665804
[TBL] [Abstract][Full Text] [Related]
2. Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn's Disease in Treatment-Naive Pediatric Patients.
Rosen MJ; Karns R; Vallance JE; Bezold R; Waddell A; Collins MH; Haberman Y; Minar P; Baldassano RN; Hyams JS; Baker SS; Kellermayer R; Noe JD; Griffiths AM; Rosh JR; Crandall WV; Heyman MB; Mack DR; Kappelman MD; Markowitz J; Moulton DE; Leleiko NS; Walters TD; Kugathasan S; Wilson KT; Hogan SP; Denson LA
Gastroenterology; 2017 May; 152(6):1345-1357.e7. PubMed ID: 28132889
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with early outcomes following standardised therapy in children with ulcerative colitis (PROTECT): a multicentre inception cohort study.
Hyams JS; Davis S; Mack DR; Boyle B; Griffiths AM; LeLeiko NS; Sauer CG; Keljo DJ; Markowitz J; Baker SS; Rosh J; Baldassano RN; Patel A; Pfefferkorn M; Otley A; Heyman M; Noe J; Oliva-Hemker M; Rufo P; Strople J; Ziring D; Guthery SL; Sudel B; Benkov K; Wali P; Moulton D; Evans J; Kappelman MD; Marquis A; Sylvester FA; Collins MH; Venkateswaran S; Dubinsky M; Tangpricha V; Spada KL; Britt A; Saul B; Gotman N; Wang J; Serrano J; Kugathasan S; Walters T; Denson LA
Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):855-868. PubMed ID: 28939374
[TBL] [Abstract][Full Text] [Related]
4. Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study.
Hyams JS; Davis Thomas S; Gotman N; Haberman Y; Karns R; Schirmer M; Mo A; Mack DR; Boyle B; Griffiths AM; LeLeiko NS; Sauer CG; Keljo DJ; Markowitz J; Baker SS; Rosh J; Baldassano RN; Patel A; Pfefferkorn M; Otley A; Heyman M; Noe J; Oliva-Hemker M; Rufo PA; Strople J; Ziring D; Guthery SL; Sudel B; Benkov K; Wali P; Moulton D; Evans J; Kappelman MD; Marquis MA; Sylvester FA; Collins MH; Venkateswaran S; Dubinsky M; Tangpricha V; Spada KL; Saul B; Wang J; Serrano J; Hommel K; Marigorta UM; Gibson G; Xavier RJ; Kugathasan S; Walters T; Denson LA
Lancet; 2019 Apr; 393(10182):1708-1720. PubMed ID: 30935734
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Host Biological Factors Predict Colectomy Risk in Children Newly Diagnosed With Ulcerative Colitis.
Hyams JS; Brimacombe M; Haberman Y; Walters T; Gibson G; Mo A; Mack D; Griffiths A; Boyle B; LeLeiko N; Markowitz J; Rosh J; Patel A; Shah S; Baldassano R; Pfefferkorn M; Sauer C; Dailey J; Venkateswaran S; Kugathasan S; Denson LA
Inflamm Bowel Dis; 2022 Feb; 28(2):151-160. PubMed ID: 33904583
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal non-adherence predicts treatment escalation in paediatric ulcerative colitis.
Carmody JK; Plevinsky J; Peugh JL; Denson LA; Hyams JS; Lobato D; LeLeiko NS; Hommel KA
Aliment Pharmacol Ther; 2019 Oct; 50(8):911-918. PubMed ID: 31373712
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic and clinical variables that predict sustained remission in children with ulcerative colitis treated with infliximab.
Turner D; Griffiths AM; Veerman G; Johanns J; Damaraju L; Blank M; Hyams J
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1460-5. PubMed ID: 23672831
[TBL] [Abstract][Full Text] [Related]
8. Early Change in Fecal Calprotectin Predicts One-Year Outcome in Children Newly Diagnosed With Ulcerative Colitis.
Krishnakumar C; Ananthakrishnan AN; Boyle BM; Griffiths AM; LeLeiko NS; Mack DR; Markowitz JF; Rosh JR; Sauer CG; Walters TD; Bonkowski E; Denson LA; Hyams JS; Kugathasan S
J Pediatr Gastroenterol Nutr; 2022 Jan; 74(1):72-78. PubMed ID: 34433783
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal DNA methylation profiling of the rectal mucosa identifies cell-specific signatures of disease status, severity and clinical outcomes in ulcerative colitis cell-specific DNA methylation signatures of UC.
Venkateswaran S; Somineni HK; Matthews JD; Kilaru V; Hyams JS; Denson LA; Kellamayer R; Gibson G; Cutler DJ; Conneely KN; Smith AK; Kugathasan S
Clin Epigenetics; 2023 Mar; 15(1):50. PubMed ID: 36964596
[TBL] [Abstract][Full Text] [Related]
10. Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up.
Bryant RV; Burger DC; Delo J; Walsh AJ; Thomas S; von Herbay A; Buchel OC; White L; Brain O; Keshav S; Warren BF; Travis SP
Gut; 2016 Mar; 65(3):408-14. PubMed ID: 25986946
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Benefit of Mesalamine Granules for Patients Who Achieved Corticosteroid-Induced Ulcerative Colitis Remission.
Lichtenstein GR; Gordon GL; Zakko S; Murthy U; Sedghi S; Pruitt R; Barrett AC; Bortey E; Paterson C; Forbes WP
Dig Dis Sci; 2016 Jan; 61(1):221-9. PubMed ID: 26563167
[TBL] [Abstract][Full Text] [Related]
12. Identification of immune-related hub genes contributing to the pathogenesis, diagnosis, and remission of ulcerative colitis by integrated bioinformatic analyses.
Zhou L; Gu Q; Huang A; Fu G; Hu X; Jiang Z
Medicine (Baltimore); 2023 Oct; 102(43):e35277. PubMed ID: 37904419
[TBL] [Abstract][Full Text] [Related]
13. Mesalamine Enemas for Induction of Remission in Oral Mesalamine-refractory Pediatric Ulcerative Colitis: A Prospective Cohort Study.
Levine A; Yerushalmi B; Kori M; Broide E; Mozer-Glassberg Y; Shaoul R; Kolho KL; Shteyer E; Shamaly H; Ledder O; Cohen S; Peleg S; Shabat CS; Focht G; Shachmon E; Boaz M; On A; Turner D
J Crohns Colitis; 2017 Aug; 11(8):970-974. PubMed ID: 28369299
[TBL] [Abstract][Full Text] [Related]
14. Early Response to Corticosteroid and Baseline C-Reactive Protein Predicts Outcomes in Children with Moderate to Severe Ulcerative Colitis.
Deva Rajoo G; Tan L; Lopez A; Lewindon P; Grover Z
Dig Dis Sci; 2019 Jul; 64(7):1929-1937. PubMed ID: 30734233
[TBL] [Abstract][Full Text] [Related]
15. Construction of a molecular inflammatory predictive model with histone modification-related genes and identification of CAMK2D as a potential response signature to infliximab in ulcerative colitis.
Ye S; Lyu Y; Chen L; Wang Y; He Y; Li Q; Tian L; Liu F; Wang X; Ai F
Front Immunol; 2023; 14():1282136. PubMed ID: 38274809
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Accuracy of Fecal Calprotectin Concentration in Evaluating Therapeutic Outcomes of Patients With Ulcerative Colitis.
Stevens TW; Gecse K; Turner JR; de Hertogh G; Rubin DT; D'Haens GR
Clin Gastroenterol Hepatol; 2021 Nov; 19(11):2333-2342. PubMed ID: 32801008
[TBL] [Abstract][Full Text] [Related]
17. A [Glyco]biomarker that Predicts Failure to Standard Therapy in Ulcerative Colitis Patients.
Pereira MS; Maia L; Azevedo LF; Campos S; Carvalho S; Dias AM; Albergaria A; Lima J; Marcos-Pinto R; Lago P; Pinho SS
J Crohns Colitis; 2019 Jan; 13(1):39-49. PubMed ID: 30239648
[TBL] [Abstract][Full Text] [Related]
18. Gene expression changes associated with resistance to intravenous corticosteroid therapy in children with severe ulcerative colitis.
Kabakchiev B; Turner D; Hyams J; Mack D; Leleiko N; Crandall W; Markowitz J; Otley AR; Xu W; Hu P; Griffiths AM; Silverberg MS
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20941359
[TBL] [Abstract][Full Text] [Related]
19. Severe eosinophilic infiltration in colonic biopsies predicts patients with ulcerative colitis not responding to medical therapy.
Zezos P; Patsiaoura K; Nakos A; Mpoumponaris A; Vassiliadis T; Giouleme O; Pitiakoudis M; Kouklakis G; Evgenidis N
Colorectal Dis; 2014 Dec; 16(12):O420-30. PubMed ID: 25040651
[TBL] [Abstract][Full Text] [Related]
20. Prediction of long-term remission in patients following discontinuation of anti-TNF therapy in ulcerative colitis: a 10 year follow up study.
Johnsen KM; Florholmen J; Moe ØK; Gundersen M; Beilfuss J; Kileng H; Sørbye SW; Goll R
BMC Gastroenterol; 2022 Nov; 22(1):459. PubMed ID: 36384477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
